Implementation of an evidence-based "standard operating procedure" and outcome in septic shock

Critical Care Medicine

Volumn 34, Issue 4, 2006, Pages 943-949

  Kortgen, Andreas ^a   Niederprüm, Petra ^b   Bauer, Michael ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Early goal directed therapy; Hydrocortisone; Intensive insulin therapy; Quality management; Recombinant human activated protein C; Standard operating procedure

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; DOBUTAMINE; DROTRECOGIN; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INSULIN; LACTIC ACID; NORADRENALIN; VASOPRESSIN;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD GAS ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; EVIDENCE BASED MEDICINE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITAL BED CAPACITY; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; RETROSPECTIVE STUDY; SEPTIC SHOCK; STRESS; SURVIVAL; THROMBOCYTE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; ALGORITHMS; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 33645076841     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000206112.32673.D4     Document Type: Article

References (24)

1. Dellinger RP, Carlet JM, Masur H, et al: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
2. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
3. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
4. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
5. Meehan TP, Fine MJ, Krumholz HM, et al: Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-2084
6. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
7. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fluorocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
8. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
9. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
10. Members of the American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
11. Vincent JL, Moreno R, Willatts S, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22:707-710
12. Genahr A, McLuckie A: Transpulmonary thermodilution in the critically ill. Br J Intens Care 2004; 14:6-10
13. Dünser M, Wenzel V, Mayr AJ, et al: Arginine vasopressin in vasodilatory shock: A new therapy approach? Anaesthesist 2002; 51:650-659
14. Slade E, Tamber PS, Vincent JL: The Surviving Sepsis Campaign: Raising awareness to reduce mortality. Critical Care 2003; 7:1-2
15. Vincent JL, Abraham E, Annane D, et al: Reducing mortality in sepsis: New directions. Critical Care 2002; 6(S3):S1-S18
16. Fox KM, Mulcahy D, Findlay I, et al: The Total Ischaemic Burden European Trial (TIBET): Effects of atenolol, nifedipin SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina: The TIBET Study Group. Eur Heart J 1996; 17:96-103
17. Savonitto S, Ardissiono D, Egstrup K, et al: Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris: Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 1996; 27:311-316
18. Ely EW, Meade MO, Haponik EF, et al: Mechanical ventilator weaning protocols driven by nonphysician health-care professionals: Evidence-based clinical practice guidelines. Chest 2001; 120:454S-463S
19. Villar J, Kacmarek RM, Hedenstierna G: From ventilator-induced lung injury to physician-induced lung injury: Why the reluctance to use small tidal volumes? Acta Anaesthesiol Scand 2004; 48:267-271
20. Ely EW, Laterre PF, Angus DC, et al: Drotrecogin alfa (activated) administrationacross clinically important subgroups of patients with severe sepsis. Crit Care Med 2003; 31:12-19
21. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
22. Kanji S, Singh A, Tierney M, et al: Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004; 30:1630-1637
23. Salem M, Tainsh RE Jr, Bromberg J, et al: Perioperative glucocorticoid coverage: A reassessment 42 years after emergence of a problem. Ann Surg 1994; 219:416-425
24. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732